2-oxothiazolidine-4-carboxylic acid has been researched along with Airway Remodeling in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, MS; Kim, SR; Lee, HB; Lee, KS; Lee, SJ; Lee, YC; Park, SJ; Park, SY | 1 |
1 other study(ies) available for 2-oxothiazolidine-4-carboxylic acid and Airway Remodeling
| Article | Year |
|---|---|
L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF).
Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Basic Helix-Loop-Helix Transcription Factors; Drug Evaluation, Preclinical; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; MAP Kinase Signaling System; Mice, Inbred C57BL; Muscle, Smooth; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pyrrolidonecarboxylic Acid; Thiazolidines; Thioctic Acid; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2012 |